Background Biologic disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic DMARDs are used in patients with psoriatic arthritis (PsA), but few studies directly compare their clinical ...
Objective: To describe the joint manifestations associated with clonal haematopoiesis and to compare patients with and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback